JUVÉDERM® VOLUX™ XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE

Go back to JUVÉDERM® VOLUX™ XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE
AbbVie (NYSE: ABBV) Delayed: 266.69 +0.93 (0.35%)
Previous Close $265.76    52 Week High $68.12 
Open $267.74    52 Week Low $50.71 
Day High $268.86    P/E 57.85 
Day Low $260.62    EPS $4.61 
Volume 4,501,057